1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India: Year-over-year growth 2024-2029 (%)
- Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Active Pharmaceutical Ingredient (API) Market in India 2019 - 2023
- Historic Market Size - Data Table on Active Pharmaceutical Ingredient (API) Market in India 2019 - 2023 ($ million)
- 5.2 Manufacturing Type segment analysis 2019 - 2023
- Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.4 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
- 5.5 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Active Pharmaceutical Ingredient (API) Market in India
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Manufacturing Type
- 8.1 Market segments
- Chart on Manufacturing Type - Market share 2024-2029 (%)
- Data Table on Manufacturing Type - Market share 2024-2029 (%)
- 8.2 Comparison by Manufacturing Type
- Chart on Comparison by Manufacturing Type
- Data Table on Comparison by Manufacturing Type
- 8.3 Captive APIs - Market size and forecast 2024-2029
- Chart on Captive APIs - Market size and forecast 2024-2029 ($ million)
- Data Table on Captive APIs - Market size and forecast 2024-2029 ($ million)
- Chart on Captive APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Captive APIs - Year-over-year growth 2024-2029 (%)
- 8.4 Contract APIs - Market size and forecast 2024-2029
- Chart on Contract APIs - Market size and forecast 2024-2029 ($ million)
- Data Table on Contract APIs - Market size and forecast 2024-2029 ($ million)
- Chart on Contract APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Contract APIs - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ million)
- Data Table on Market opportunity by Manufacturing Type ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 Innovative APIs - Market size and forecast 2024-2029
- Chart on Innovative APIs - Market size and forecast 2024-2029 ($ million)
- Data Table on Innovative APIs - Market size and forecast 2024-2029 ($ million)
- Chart on Innovative APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Innovative APIs - Year-over-year growth 2024-2029 (%)
- 9.4 Generic APIs - Market size and forecast 2024-2029
- Chart on Generic APIs - Market size and forecast 2024-2029 ($ million)
- Data Table on Generic APIs - Market size and forecast 2024-2029 ($ million)
- Chart on Generic APIs - Year-over-year growth 2024-2029 (%)
- Data Table on Generic APIs - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Product Type
- 10.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
- 10.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- 10.3 Prescription - Market size and forecast 2024-2029
- Chart on Prescription - Market size and forecast 2024-2029 ($ million)
- Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
- Chart on Prescription - Year-over-year growth 2024-2029 (%)
- Data Table on Prescription - Year-over-year growth 2024-2029 (%)
- 10.4 Over-the-counter (OTC) - Market size and forecast 2024-2029
- Chart on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million)
- Data Table on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million)
- Chart on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%)
- Data Table on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
11 Market Segmentation by Application
- 11.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 11.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 11.3 Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029
- Chart on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%)
- 11.4 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 11.5 Infectious diseases - Market size and forecast 2024-2029
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
- 11.6 Diabetes - Market size and forecast 2024-2029
- Chart on Diabetes - Market size and forecast 2024-2029 ($ million)
- Data Table on Diabetes - Market size and forecast 2024-2029 ($ million)
- Chart on Diabetes - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
- 11.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 11.8 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Drivers, Challenges, and Opportunity/Restraints
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 15.5 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
- 15.6 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- 15.7 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- 15.8 Divis Laboratories Ltd.
- Divis Laboratories Ltd. - Overview
- Divis Laboratories Ltd. - Product / Service
- Divis Laboratories Ltd. - Key offerings
- SWOT
- 15.9 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 15.10 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- 15.11 Granules India Ltd.
- Granules India Ltd. - Overview
- Granules India Ltd. - Product / Service
- Granules India Ltd. - Key news
- Granules India Ltd. - Key offerings
- SWOT
- 15.12 IOL Chemicals and Pharmaceuticals Ltd.
- IOL Chemicals and Pharmaceuticals Ltd. - Overview
- IOL Chemicals and Pharmaceuticals Ltd. - Business segments
- IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
- IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
- SWOT
- 15.13 Ipca Laboratories
- Ipca Laboratories - Overview
- Ipca Laboratories - Product / Service
- Ipca Laboratories - Key offerings
- SWOT
- 15.14 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key news
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
- 15.15 Laurus Labs Ltd.
- Laurus Labs Ltd. - Overview
- Laurus Labs Ltd. - Product / Service
- Laurus Labs Ltd. - Key offerings
- SWOT
- 15.16 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 15.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 15.18 Torrent Pharmaceuticals Ltd.
- Torrent Pharmaceuticals Ltd. - Overview
- Torrent Pharmaceuticals Ltd. - Business segments
- Torrent Pharmaceuticals Ltd. - Key offerings
- Torrent Pharmaceuticals Ltd. - Segment focus
- SWOT
16 Appendix
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.